How Saxenda works
Saxenda contains liraglutide, a GLP-1 receptor agonist. It reduces appetite and increases fullness, helping you eat fewer calories. Unlike Wegovy or Mounjaro, it is injected daily rather than weekly.
Dose escalation schedule, BMI eligibility check and estimated weight loss for Saxenda (liraglutide), a daily injection.
Saxenda is injected DAILY (not weekly), with the dose increased every week until the 3.0 mg maintenance dose.
A strictly educational, indicative tool. It does not replace medical advice and does not give dosing instructions. Saxenda (liraglutide) is a prescription medicine: only the prescribing doctor decides eligibility and dose.
Potentially eligible under EMA criteria
Indicative criteria: BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition. The final decision is your doctor's.
BMI does not distinguish muscle from fat and has limitations (athletes, older adults, pregnancy).
In the SCALE trial, adults treated with liraglutide 3.0 mg daily lost on average about 8% of their starting body weight at 56 weeks.
Saxenda contains liraglutide, a GLP-1 receptor agonist. It reduces appetite and increases fullness, helping you eat fewer calories. Unlike Wegovy or Mounjaro, it is injected daily rather than weekly.
These treatments reduce appetite, so you will eat less, which makes the quality of every meal even more important. A good diet prevents nutritional deficiencies, protects muscle mass and improves digestive tolerance. Ideally, your eating plan is put together with a doctor or registered dietitian, rather than simply eating smaller portions.
With rapid weight loss there is a risk of losing muscle as well as fat. Eating enough protein, spread across every meal, helps preserve muscle and keeps you full for longer.
Fibre keeps you full for longer, softens blood sugar spikes and helps prevent constipation, a common side effect of these treatments.
Drink water steadily throughout the day, since dehydration makes nausea and constipation worse. Choose small, frequent meals, eat slowly and stop at the first sign of fullness. Limit very fatty, fried and ultra-processed foods and concentrated sweets, as they make nausea worse. Keep alcohol moderate: it adds empty calories and irritates the stomach.
Saxenda is injected under the skin once a day, at about the same time each day. The dose increases every week (0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg) to reduce digestive side effects.
In the SCALE trial, average weight loss was about 8% of body weight at 56 weeks on the 3.0 mg dose. Individual results vary.
Saxenda (liraglutide) is injected daily, while Wegovy (semaglutide) is injected weekly; in trials, semaglutide showed greater average weight loss. The choice is up to your doctor.
It is an educational tool for patients and healthcare professionals who want to understand the dose escalation schedule, the eligibility criteria and the average results seen in clinical trials. It is not a medical device and does not give personalised recommendations.
No. The figures are averages from clinical trials. Your individual result depends on diet, physical activity, adherence to treatment, dose and medical factors. Some people lose more weight, others less.
Increasing the dose step by step reduces digestive side effects (nausea, vomiting, diarrhoea). Your doctor may slow the pace if you are not tolerating it well. Do not rush and do not skip steps.
Sources and limitations
The dose escalation schedule follows the summary of product characteristics (SmPC/EMA). Average results come from the SCALE trial. The eligibility criteria (BMI ≥ 30, or ≥ 27 with weight-related conditions) are indicative.
This calculator does not diagnose or prescribe treatment. For any medical decision, talk to your doctor and read the approved patient leaflet.EMA
Content last reviewed: 19 August 2026.